These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. In vivo tau PET imaging in dementia: Pathophysiology, radiotracer quantification, and a systematic review of clinical findings. Hall B; Mak E; Cervenka S; Aigbirhio FI; Rowe JB; O'Brien JT Ageing Res Rev; 2017 Jul; 36():50-63. PubMed ID: 28315409 [TBL] [Abstract][Full Text] [Related]
7. Nuclear medicine imaging in dementia: a practical overview for hospitalists. Toney LK; McCue TJ; Minoshima S; Lewis DH Hosp Pract (1995); 2011 Aug; 39(3):149-60. PubMed ID: 21881402 [TBL] [Abstract][Full Text] [Related]
8. The bivariate distribution of amyloid-β and tau: relationship with established neurocognitive clinical syndromes. Jack CR; Wiste HJ; Botha H; Weigand SD; Therneau TM; Knopman DS; Graff-Radford J; Jones DT; Ferman TJ; Boeve BF; Kantarci K; Lowe VJ; Vemuri P; Mielke MM; Fields JA; Machulda MM; Schwarz CG; Senjem ML; Gunter JL; Petersen RC Brain; 2019 Oct; 142(10):3230-3242. PubMed ID: 31501889 [TBL] [Abstract][Full Text] [Related]
9. Recommendations for the use of PET imaging biomarkers in the diagnosis of neurodegenerative conditions associated with dementia: SEMNIM and SEN consensus. Arbizu J; García-Ribas G; Carrió I; Garrastachu P; Martínez-Lage P; Molinuevo JL Rev Esp Med Nucl Imagen Mol; 2015; 34(5):303-13. PubMed ID: 26099942 [TBL] [Abstract][Full Text] [Related]
10. [Current and future prospects of nuclear medicine in dementia]. Ito K; Inui Y; Kizawa T; Kimura Y; Kato T Rinsho Shinkeigaku; 2017 Sep; 57(9):479-484. PubMed ID: 28804110 [TBL] [Abstract][Full Text] [Related]
11. Clinical Utility of Amyloid PET Imaging in the Differential Diagnosis of Atypical Dementias and Its Impact on Caregivers. Bensaïdane MR; Beauregard JM; Poulin S; Buteau FA; Guimond J; Bergeron D; Verret L; Fortin MP; Houde M; Bouchard RW; Soucy JP; Laforce R J Alzheimers Dis; 2016 Apr; 52(4):1251-62. PubMed ID: 27104896 [TBL] [Abstract][Full Text] [Related]
12. Update on appropriate use criteria for amyloid PET imaging: dementia experts, mild cognitive impairment, and education. Johnson KA; Minoshima S; Bohnen NI; Donohoe KJ; Foster NL; Herscovitch P; Karlawish JH; Rowe CC; Hedrick S; Pappas V; Carrillo MC; Hartley DM J Nucl Med; 2013 Jul; 54(7):1011-3. PubMed ID: 23753186 [TBL] [Abstract][Full Text] [Related]
13. Association of Amyloid Positron Emission Tomography With Changes in Diagnosis and Patient Treatment in an Unselected Memory Clinic Cohort: The ABIDE Project. de Wilde A; van der Flier WM; Pelkmans W; Bouwman F; Verwer J; Groot C; van Buchem MM; Zwan M; Ossenkoppele R; Yaqub M; Kunneman M; Smets EMA; Barkhof F; Lammertsma AA; Stephens A; van Lier E; Biessels GJ; van Berckel BN; Scheltens P JAMA Neurol; 2018 Sep; 75(9):1062-1070. PubMed ID: 29889941 [TBL] [Abstract][Full Text] [Related]
14. Association of Amyloid Positron Emission Tomography With Subsequent Change in Clinical Management Among Medicare Beneficiaries With Mild Cognitive Impairment or Dementia. Rabinovici GD; Gatsonis C; Apgar C; Chaudhary K; Gareen I; Hanna L; Hendrix J; Hillner BE; Olson C; Lesman-Segev OH; Romanoff J; Siegel BA; Whitmer RA; Carrillo MC JAMA; 2019 Apr; 321(13):1286-1294. PubMed ID: 30938796 [TBL] [Abstract][Full Text] [Related]
15. A Review of Diagnostic Impact of Amyloid Positron Emission Tomography Imaging in Clinical Practice. Kim Y; Rosenberg P; Oh E Dement Geriatr Cogn Disord; 2018; 46(3-4):154-167. PubMed ID: 30199882 [TBL] [Abstract][Full Text] [Related]
16. Positron emission tomography imaging in dementia. Herholz K; Carter SF; Jones M Br J Radiol; 2007 Dec; 80 Spec No 2():S160-7. PubMed ID: 18445746 [TBL] [Abstract][Full Text] [Related]
17. Clinical Relevance of [ Librizzi D; Cabanel N; Zavorotnyy M; Riehl E; Kircher T; Luster M; Hooshyar Yousefi B Molecules; 2021 Feb; 26(5):. PubMed ID: 33652938 [TBL] [Abstract][Full Text] [Related]
18. Visual Versus Fully Automated Analyses of 18F-FDG and Amyloid PET for Prediction of Dementia Due to Alzheimer Disease in Mild Cognitive Impairment. Grimmer T; Wutz C; Alexopoulos P; Drzezga A; Förster S; Förstl H; Goldhardt O; Ortner M; Sorg C; Kurz A J Nucl Med; 2016 Feb; 57(2):204-7. PubMed ID: 26585056 [TBL] [Abstract][Full Text] [Related]
19. Canadian Consensus Guidelines on Use of Amyloid Imaging in Canada: Update and Future Directions from the Specialized Task Force on Amyloid imaging in Canada. Laforce R; Rosa-Neto P; Soucy JP; Rabinovici GD; Dubois B; Gauthier S Can J Neurol Sci; 2016 Jul; 43(4):503-12. PubMed ID: 26916179 [TBL] [Abstract][Full Text] [Related]
20. PET imaging of brain amyloid in dementia: a review. Quigley H; Colloby SJ; O'Brien JT Int J Geriatr Psychiatry; 2011 Oct; 26(10):991-9. PubMed ID: 21905095 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]